News for DaVita Inc. (DVA.MX)

Summary DaVita Inc (DVA), a prominent healthcare provider specializing in kidney care, has announced that it will hold its quarterly conference call to discuss

PR NewswireDENVER, July 17, 2025 DENVER, July 17, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference

DaVita is expected to unveil its second-quarter results in the upcoming month, and analysts expect a single-digit rise in its profitability.

DaVita Inc. (NYSE:DVA) is one of the 12 Best Stocks to Invest in for Good Returns. On June 18, DaVita Inc. (NYSE:DVA) released its Community Care report, highlighting its long-standing commitment to corporate citizenship and development towards ESG goals for 2025. DaVita Inc. posted its major developments in 2024. In 2020, the company announced broadened […]

Summary On July 3, 2025, DaVita Inc (DVA), a leading healthcare provider specializing in kidney care, released a press statement highlighting the compassionate

NORTHAMPTON, MA / ACCESS Newswire / July 3, 2025 / Frank's teammates really stepped up during his time of need and showed they genuinely care about him. That's

DaVita’s performance over the past year has fallen short of the broader S&P 500 Index, prompting a neutral outlook from analysts regarding its future prospects.

During the Berkshire Hathaway annual meeting on May 3 in Omaha, Warren Buffett announced that he would step down as CEO of the company at the end of 2025 and pass the reins to Vice Chairman Greg Abel, ...

Summary On June 20, 2025, DaVita Inc (DVA) announced its ongoing commitment to revolutionizing kidney care through technological advancements. CEO Javier Rodrig

Summary DaVita Inc (DVA), a leading health care provider, has published its Community Care report on June 18, 2025, showcasing significant progress in its Envir

Captures key initiatives achieved in 2024, driving 2025 ESG goals DENVER, CO / ACCESS Newswire / June 18, 2025 / DaVita (NYSE:DVA) published its Community Care

DaVita Inc. (DVA) recently held its virtual 2025 Annual Meeting of Stockholders on June 5, 2025. The meeting saw participation from shareholders representing

Summary DaVita Inc (DVA), a leading comprehensive kidney care company, has expressed its support for the Center for Medicare and Medicaid Innovation's (CMMI) de

Summary: DaVita Inc. (DVA) boosts its senior notes offering to $1 billion with plans to use proceeds for debt repayment. Analyst forecasts suggest a 13.1

Truist has revised its price target for DaVita (DVA), lowering it from $170 to $164, while maintaining a Hold rating on the shares. This adjustment follows an a

On May 19, 2025, analyst David Macdonald from Truist Securities released a report on DaVita (DVA), maintaining a "Hold" rating but lowering the price target fro

TD Cowen's analyst, Gary Taylor, has adjusted the target price for DaVita (DVA), decreasing it from $165 to $157 while maintaining a Hold rating on the stock. T

The move occurred just a day before a union health benefits fund sued top dialysis services providers in the country, including DaVita Inc.

According to a Form 4 filing with the United States Securities and Exchange Commission, on May 8, Berkshire Hathaway sold 1,145,938 shares of DaVita Inc. (NYSE:DVA), valued at $168.58 million. The move occurred just a day before a union health benefits fund sued top dialysis services providers in the country, including DaVita Inc. (NYSE:DVA), for […]